Physician

Benjamin Jospeh Vaccaro, MD

According to 2025 Medicare claims, Benjamin Vaccaro, MD (NPI: 1295027936) practices advanced heart failure and transplant cardiology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY, PC (NPI: 1902844806; TIN: 232865181) and primary practice location at 19104-2640. Vaccaro is affiliated with the Northeast Medical Group ACO, LLC (ACO ID: A2695) and Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Vaccaro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,078 traditional Medicare patients, billed 3,007 HCPCS/CPT codes, and received $149,845 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 3,415 prescription claims across 433 beneficiaries totaling $2,412,426 in drug costs, led by Vyndamax (Tafamidis). DME data shows 110 claims. Open Payments data shows 52 records totaling $4,659. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $60,597 to $149,845. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,676 to $2,412,426. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	434	1,241	$60,597
2019	870	2,130	$111,260
2020	907	1,946	$123,420
2021	1,162	2,688	$164,130
2022	1,211	2,703	$143,452
2023	1,121	2,651	$143,499
2024	1,078	3,007	$149,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	12	69	$1,676
2016	N/R	45	$408
2017	15	63	$1,768
2018	126	415	$27,415
2019	207	1,100	$101,839
2020	188	749	$121,621
2021	276	1,581	$339,956
2022	378	2,633	$1,030,788
2023	397	2,857	$1,108,538
2024	433	3,415	$2,412,426

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	36	$18,602
2021	N/R	129	$28,307
2022	N/R	147	$28,236
2023	N/R	154	$7,294
2024	N/R	110	$4,714

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	361	367	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	235	334	$94
93356	Heart muscle strain imaging	266	269	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	290	409	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	300	403	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	27	810	$573,963
Entresto	Sacubitril/Valsartan	250	17,568	$373,782
Camzyos	Mavacamten	44	1,320	$347,881
Vyndaqel	Tafamidis Meglumine	16	480	$320,084
Eliquis	Apixaban	213	13,303	$246,958

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	37	$3,205
J2260	Injection, milrinone lactate, 5 mg	N	N/R	37	$818
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	36	$691

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$4,659	Impulse Dynamics (USA) Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Jospeh Vaccaro, MD?

Tedicare shows public-source Medicare data for Benjamin Jospeh Vaccaro, MD (NPI 1295027936), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Jospeh Vaccaro, MD have ACO affiliation data?

Benjamin Jospeh Vaccaro, MD is shown with ACO affiliation data for Northeast Medical Group ACO, LLC (MSSP, ACO ID A2695) and Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Benjamin Jospeh Vaccaro, MD?

Benjamin Jospeh Vaccaro, MD is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY, PC (billing NPI 1902844806) in the available physician profile data.

Does Benjamin Jospeh Vaccaro, MD have Open Payments data?

Benjamin Jospeh Vaccaro, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.